>>14706432 pb
here is the article.
Molnupiravir - What Wrong With America? Why Is the American Government And Agencies Funding And Pushing Potentially Toxic Drugs To Treat COVID-19?
In April 2020, a whistleblower complaint by former Head of US Biomedical Advanced Research and Development Authority (BARDA) Rick Bright revealed concerns over providing funding for the further development of molnupiravir due to similar drugs having mutagenic (DNA damaging) properties.
https://cen.acs.org/pharmaceuticals/drug-development/emerging-antiviral-takes-aim-COVID-19/98/web/2020/
A previous company, Pharmasset, that had investigated the drug's active ingredient and because of toxicity issues, had abandoned it. Rumour has yet that in order to keep the mouth of executives at Pharmasset shut about what they knew about molnupiravir and other drugs, the company was bought at an inflated price.
All these claims were denied by George Painter, CEO of DRIVE, noting that toxicity studies on molnupiravir had been carried out and data provided to regulators in the US and UK, who permitted safety studies in humans to move forward in the spring of 2020. Also at this time, DRIVE and Ridgeback Biotherapeutics stated they planned future safety studies in animals.
https://www.science.org/news/2020/05/emails-offer-look-whistleblower-charges-cronyism-behind-potential-covid-19-
drug
On May 5, 2020, Bright filed a whistleblower complaint ("Complaint of Prohibited Personnel Practice and Other Prohibited Activity") against the HHS in the U.S. Office of Special Counsel, an independent agency that protects whistleblowers. The complaint included accompanying exhibits, only some of which have become public. https://context-cdn.washingtonpost.com/notes/prod/default/documents/800d4444-437b-4fcf-aff5-c2db665778b0 /note/b2f67b4a-526a-4566-80f3-1acb60be79f6.
https://www.thailandmedical.news/news/molnupiravir–what-wrong-with-america-why-is-the-american-government-and-agencies-funding-and-pushing-potentially-toxic-drugs-to-treat-covid-19